Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, Lanfear R
Dual Incretin Research Peptide GLP-1/GIP Receptor Agonist Overview This dual incretin research peptide is a synthetic GLP-1R/GIPR co-agonist studied in preclinical metabolic research models for its coordinated activation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathways
Once signed up to a Refills program, users benefit from the best clinical providers who follow the latest established protocols when determining eligibility, personalizing, and prescribing medication
The research protocol was performed with the approval of the Ethics Committee of Harbin Institute of Technology (Approval No: HIT-2022008)
Whether youre using semaglutide or tirzepatide, picking the right spot to inject can make a big difference in comfort and effectiveness
Both peptides remain research tools, and substantial clinical investigation would be required before any therapeutic applications could be considered